BriaCell Therapeutics Corp. (BCTXW)

NASDAQ: BCTXW · Real-Time Price · USD · Warrants
0.0334
-0.0156 (-31.84%)
At close: Jul 15, 2025, 4:00 PM
0.0203
-0.0131 (-39.22%)
After-hours: Jul 15, 2025, 7:58 PM EDT
-31.84%
Market Cap 5.23M
Revenue (ttm) n/a
Net Income (ttm) -19.43M
Shares Out 6.78M
EPS (ttm) -8.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 210,722
Open 0.0691
Previous Close 0.0490
Day's Range 0.0300 - 0.0700
52-Week Range 0.0238 - 0.7000
Beta 1.72
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2025

About BCTXW

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. I... [Read more]

Industry Biotechnology
Sector Healthcare
CEO William Williams
Employees 16
Stock Exchange NASDAQ
Ticker Symbol BCTXW
Full Company Profile

News

There is no news available yet.